Novartis AG is 128.9x more valuable than Enliven Therapeutics, Inc. by market capitalization ($283.13 B vs $2.20 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ELVN | NVS |
|---|---|---|
| Market cap | $2.20 B | $283.13 B |
| US-listed rank | #2035 | #47 |
| Net income (latest FY) | -$103.70M | - |
| SEC filings | 750 | 947 |
Novartis AG is 128.9x more valuable than Enliven Therapeutics, Inc. by market capitalization ($283.13 B vs $2.20 B).
Full pages: Enliven Therapeutics, Inc. and Novartis AG, or browse the full rankings.